Indonesia has achieved a historic milestone in cardiovascular medicine with the first successful implantation of the world’s smallest and lightest Left Ventricular Assist Device (LVAD) at Dr. Cipto Mangunkusumo General Hospital (RSCM) on Aug. 1.The recipient was a 45-year-old woman with advanced heart failure and a severely reduced left ventricular ejection fraction of just 14 percent, who experienced shortness of breath during light physical activity and had been hospitalized repeatedly due to heart failure, the hospital said in a joint statement with partner HeartSpan.ai.
“This successful procedure represents a major advancement in Indonesia's capability to provide world-class treatment for patients with end-stage heart failure,” the statement said on Aug. 5.
The achievement follows a strategic collaboration between RSCM and HeartSpan.ai, the heart longevity division of Borderless Healthcare Group (BHG), which was launched one week earlier through the LVAD Donation Ceremony.
Within days of receiving the donated device from HeartSpan.ai and completing the intensive clinical training program at Fuwai Hospital in Beijing, the world's largest cardiovascular center, the cardiovascular team at RSCM, with the support of specialists from Fuwai Hospital on-site, successfully performed the country's inaugural LVAD implantation.
